Stewart Fisher
Chief Tech/Sci/R&D Officer at C4 THERAPEUTICS, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Stewart Fisher is currently the Chief Scientific Officer at C4 Therapeutics, Inc. He previously worked as the Executive Director-Infection Bioscience at AstraZeneca PLC from 1988 to 2013.
Additionally, he held the position of Director-Quantitative, Biochemistry & Enzymology at The Broad Institute, Inc. He also served as the Head-Metabolic Diseases Department at Hoffmann-La Roche, Inc. from 1996 to 1998.
Dr. Fisher holds a doctorate degree from the California Institute of Technology and an undergraduate degree from the University of Vermont.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
C4 THERAPEUTICS, INC.
0.19% | 2024-03-06 | 129,121 ( 0.19% ) | 1 M $ | 2024-03-30 |
Stewart Fisher active positions
Companies | Position | Start |
---|---|---|
C4 THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-04-30 |
Former positions of Stewart Fisher
Companies | Position | End |
---|---|---|
ASTRAZENECA PLC | Corporate Officer/Principal | 2013-07-31 |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 1998-07-31 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Stewart Fisher
California Institute of Technology | Doctorate Degree |
University of Vermont | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
C4 THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Stewart Fisher